{"id":50783,"date":"2025-12-16T15:58:05","date_gmt":"2025-12-16T13:58:05","guid":{"rendered":"https:\/\/www.cobalt.legal\/?p=50783"},"modified":"2025-12-16T16:00:25","modified_gmt":"2025-12-16T14:00:25","slug":"exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses","status":"publish","type":"post","link":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/","title":{"rendered":"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses"},"content":{"rendered":"<p>COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu. Riigikohus kinnitas, et olukorras, kus hagi on tagatud hiljem t\u00fchistatud IP-\u00f5iguse kaitseks, vastutab taotlenud ettev\u00f5tja tekitatud kahju eest s\u00f5ltumata s\u00fc\u00fcst. Vaidlus j\u00e4tkub ringkonnakohtus l\u00e4htuvalt Riigikohtu suunistest tekitatud kahju (sh saamata j\u00e4\u00e4nud tulu) suuruse kindlaks tegemiseks.<\/p>\n<p>Ravimiga plaanitud ajal turule tulemise viibimine v\u00f5ib t\u00e4hendada miljonitesse ulatuvat kahju. Riigikohtu otsus toob nii originaal- kui ka geneerilise ravimi m\u00fc\u00fcjatele kaua oodatud selguse: hiljem t\u00fchistatud IP-\u00f5iguse kaitseks kohaldatud hagi tagamise abin\u00f5uga teisele turuosalisele turult t\u00f5rjumisega tekitatud kahju kuulub h\u00fcvitamisele s\u00f5ltumata taotleja s\u00fc\u00fcst.<\/p>\n<p>Riigikohus selgitas ka k\u00fcsimust sellest, kas ja mis ulatuses kuulub hagi tagamisega tekitatud kahju h\u00fcvitamisele kolmandale isikule, kes ei ole menetlusosaline. Sellisel juhul ei vastuta hagi tagamist taotlenud isik kolmandale isikule tekitatud kahju eest erinormi alusel, vaid vastutust tekitatud kahju eest tuleb kontrollida delikti \u00fcldkoosseisu j\u00e4rgi.<\/p>\n<p>Samuti leiab lahendist olulised juhtn\u00f6\u00f6rid saamata j\u00e4\u00e4nud tulu suuruse v\u00e4lja selgitamiseks, mis on praktikas keerukas vaidlusk\u00fcsimus. Riigikohus selgitas, kuidas jaguneb poolte t\u00f5endamiskoormis, millised kulud peavad olema h\u00fcvitisest maha arvatud ning et saamata j\u00e4\u00e4nud tulu saab kindlaks teha ka ettev\u00f5tte keskmisest kasumimarginaalist l\u00e4htudes.<\/p>\n<p>Exeltis Baltics esindavad COBALTi valdkonnajuht <a href=\"https:\/\/www.cobalt.legal\/et\/people\/kadri-michelson\/\">Kadri Michelson<\/a> ja advokaat <a href=\"https:\/\/www.cobalt.legal\/et\/people\/anna-riin-brett\/\">Anna-Riin Brett<\/a>.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu. Riigikohus kinnitas, et olukorras, kus hagi on tagatud hiljem t\u00fchistatud IP-\u00f5iguse kaitseks, vastutab taotlenud ettev\u00f5tja tekitatud kahju eest s\u00f5ltumata s\u00fc\u00fcst. Vaidlus..<\/p>\n","protected":false},"author":21,"featured_media":50124,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[28],"country":[84],"class_list":["post-50783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-et","country-estonia-et"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses | COBALT<\/title>\n<meta name=\"description\" content=\"COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses | COBALT\" \/>\n<meta property=\"og:description\" content=\"COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/\" \/>\n<meta property=\"og:site_name\" content=\"COBALT\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CobaltLegal\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-16T13:58:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-16T14:00:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/white-abstract-5.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1518\" \/>\n\t<meta property=\"og:image:height\" content=\"1214\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liisa Kaseorg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liisa Kaseorg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/\"},\"author\":{\"name\":\"Liisa Kaseorg\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/person\\\/d8b0370f727b4cacfc77cf53eb401d17\"},\"headline\":\"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses\",\"datePublished\":\"2025-12-16T13:58:05+00:00\",\"dateModified\":\"2025-12-16T14:00:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/\"},\"wordCount\":239,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/white-abstract-5.jpg\",\"articleSection\":[\"Uncategorized @et\"],\"inLanguage\":\"et-EE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/\",\"name\":\"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses | COBALT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/white-abstract-5.jpg\",\"datePublished\":\"2025-12-16T13:58:05+00:00\",\"dateModified\":\"2025-12-16T14:00:25+00:00\",\"description\":\"COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/#breadcrumb\"},\"inLanguage\":\"et-EE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et-EE\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/white-abstract-5.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/white-abstract-5.jpg\",\"width\":1518,\"height\":1214},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/\",\"name\":\"COBALT\",\"description\":\"Top-tier law services in Estonia, Latvia and Lithuania\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et-EE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#organization\",\"name\":\"COBALT\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et-EE\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"width\":400,\"height\":116,\"caption\":\"COBALT\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CobaltLegal\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/person\\\/d8b0370f727b4cacfc77cf53eb401d17\",\"name\":\"Liisa Kaseorg\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/author\\\/liisa\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses | COBALT","description":"COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/","og_locale":"et_EE","og_type":"article","og_title":"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses | COBALT","og_description":"COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu.","og_url":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/","og_site_name":"COBALT","article_publisher":"https:\/\/www.facebook.com\/CobaltLegal\/","article_published_time":"2025-12-16T13:58:05+00:00","article_modified_time":"2025-12-16T14:00:25+00:00","og_image":[{"width":1518,"height":1214,"url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/white-abstract-5.jpg","type":"image\/jpeg"}],"author":"Liisa Kaseorg","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liisa Kaseorg","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/#article","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/"},"author":{"name":"Liisa Kaseorg","@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/person\/d8b0370f727b4cacfc77cf53eb401d17"},"headline":"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses","datePublished":"2025-12-16T13:58:05+00:00","dateModified":"2025-12-16T14:00:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/"},"wordCount":239,"publisher":{"@id":"https:\/\/www.cobalt.legal\/et\/#organization"},"image":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/white-abstract-5.jpg","articleSection":["Uncategorized @et"],"inLanguage":"et-EE"},{"@type":"WebPage","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/","url":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/","name":"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses | COBALT","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/#primaryimage"},"image":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/white-abstract-5.jpg","datePublished":"2025-12-16T13:58:05+00:00","dateModified":"2025-12-16T14:00:25+00:00","description":"COBALT esindab Exeltis Baltics-d, kellel oli aastateks takistatud geneerilise ravimiga Eesti turule tulek originaalravimi m\u00fc\u00fcja taotletud hagi tagamise t\u00f5ttu.","breadcrumb":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/#breadcrumb"},"inLanguage":"et-EE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/"]}]},{"@type":"ImageObject","inLanguage":"et-EE","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/#primaryimage","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/white-abstract-5.jpg","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/white-abstract-5.jpg","width":1518,"height":1214},{"@type":"BreadcrumbList","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/exeltis-baltics-sai-riigikohtust-olulise-vahevoidu-intellektuaalomandi-oiguse-vaidluses\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cobalt.legal\/et\/"},{"@type":"ListItem","position":2,"name":"Exeltis Baltics sai Riigikohtust olulise vahev\u00f5idu intellektuaalomandi \u00f5iguse vaidluses"}]},{"@type":"WebSite","@id":"https:\/\/www.cobalt.legal\/et\/#website","url":"https:\/\/www.cobalt.legal\/et\/","name":"COBALT","description":"Top-tier law services in Estonia, Latvia and Lithuania","publisher":{"@id":"https:\/\/www.cobalt.legal\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cobalt.legal\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et-EE"},{"@type":"Organization","@id":"https:\/\/www.cobalt.legal\/et\/#organization","name":"COBALT","url":"https:\/\/www.cobalt.legal\/et\/","logo":{"@type":"ImageObject","inLanguage":"et-EE","@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","width":400,"height":116,"caption":"COBALT"},"image":{"@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CobaltLegal\/"]},{"@type":"Person","@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/person\/d8b0370f727b4cacfc77cf53eb401d17","name":"Liisa Kaseorg","url":"https:\/\/www.cobalt.legal\/et\/author\/liisa\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts\/50783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/comments?post=50783"}],"version-history":[{"count":3,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts\/50783\/revisions"}],"predecessor-version":[{"id":50788,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts\/50783\/revisions\/50788"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/media\/50124"}],"wp:attachment":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/media?parent=50783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/categories?post=50783"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/country?post=50783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}